How are uranium prices determined?
This is one of the questions UxC is often asked. We have developed a brief overview to discuss this question.
In addition to the Ux Prices, below is some general information concerning other sources of price information in the nuclear industry.
CME/NYMEX Partners with UxC to Offer Uranium Futures Contracts
On April 13, 2007, UxC and CME/NYMEX issued a joint press release
announcing the introduction of on and off-exchange traded uranium futures products on the CME Globex®
and CME ClearPort® electronic platforms on May 6 for the May 7, 2007 trade date.
Effective Sunday, July 12, 2020, the UxC Uranium U308 futures contract (UX) was transferred from the NYMEX Designated Contract Market (DCM) to the COMEX DCM.
Additional information on the CME/COMEX UX contract is available on this site.
Over the past several years, uranium has moved closer to commodities-style trading.
A number of new participants have entered the market providing a wide variety of services.
Included in this group are the UxC Participating Brokers: Evolution Markets and Numerco Limited.
Additional information on the UxC Broker Average Price (BAP) is available on this site.
Other related sources of price and indexes will also be provided as they become available. See below for additional information related to the nuclear industry.
On July 19, 2021, and based on shareholder approval on July 7, 2021, Uranium Participation Corporation ("UPC") was reorganized into the
Sprott Physical Uranium Trust (SPUT).
The Trust's goal is to provide a secure, convenient and exchange-traded investment alternative for investors interested in holding uranium.
The Trust is the first offering in the marketplace that allows individuals to invest directly in physical uranium through a transparent, cost-effective and liquid trust investment structure.
The shares are listed on the Toronto Stock Exchange under the symbol "U.U" ($US) and "U.UN" ($CA).
Yellow Cake plc is a specialist company operating in the uranium sector,
founded and established by Bacchus Capital Advisers (“Bacchus Capital”) to purchase and hold uranium oxide (“U3O8”), with the objectives of:
1) offering shareholders exposure to the uranium price; and
2) exploiting a range of expected opportunities connected with owning physical U3O8 and uranium based financial initiatives such as commodity streaming and royalties.
The shares are listed on the London Stock Exchange under the symbol "YCA".